Jul 5 |
Dupixent “addresses current gap” in COPD biologics landscape
|
Jul 4 |
7 High Priced Stocks That Would Benefit From a Stock Split
|
Jul 3 |
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
|
Jul 3 |
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
|
Jul 3 |
Sanofi, Regeneron win EU label expansion for Dupixent in COPD
|
Jul 3 |
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
|
Jul 2 |
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
|
Jul 2 |
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
|
Jul 1 |
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
|
Jun 28 |
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
|